Show simple item record

AuthorMoghei, Mahshid
AuthorTurk-Adawi, Karam
AuthorIsaranuwatchai, Wanrudee
AuthorSarrafzadegan, Nizal
AuthorOh, Paul
AuthorChessex, Caroline
AuthorGrace, Sherry L.
Available date2017-06-18T06:41:16Z
Publication Date2017-06-10
Publication NameInternational Journal of Cardiology
Identifierhttp://dx.doi.org/10.1016/j.ijcard.2017.06.030
CitationMahshid Moghei, Karam Turk-Adawi, Wanrudee Isaranuwatchai, Nizal Sarrafzadegan, Paul Oh, Caroline Chessex, Sherry L. Grace, Cardiac rehabilitation costs, International Journal of Cardiology, Available online 10 June 2017
ISSN01675273
URIhttp://www.sciencedirect.com/science/article/pii/S0167527317332291
URIhttp://hdl.handle.net/10576/5576
AbstractBackground Despite the clinical benefits of cardiac rehabilitation (CR) and its cost-effectiveness, it is not widely received. Arguably, capacity could be greatly increased if lower-cost models were implemented. The aims of this review were to describe: the costs associated with CR delivery, approaches to reduce these costs, and associated implications. Methods Upon finalizing the PICO statement, information scientists were enlisted to develop the search strategy of MEDLINE, Embase, CDSR, Google Scholar and Scopus. Citations identified were considered for inclusion by the first author. Extracted cost data were summarized in tabular format and qualitatively synthesized. Results There is wide variability in the cost of CR delivery around the world, and patients pay out-of-pocket for some or all of services in 55% of countries. Supervised CR costs in high-income countries ranged from PPP$294 (Purchasing Power Parity; 2016 United States Dollars) in the United Kingdom to PPP$12,409 in Italy, and in middle-income countries ranged from PPP$146 in Venezuela to PPP$1095 in Brazil. Costs relate to facilities, personnel, and session dose. Delivering CR using information and communication technology (mean cost PPP$753/patient/program), lowering the dose and using lower-cost personnel and equipment are important strategies to consider in containing costs, however few explicitly low-cost models are available in the literature. Conclusion More research is needed regarding the costs to deliver CR in community settings, the cost-effectiveness of CR in most countries, and the economic impact of return-to-work with CR participation. A low-cost model of CR should be standardized and tested for efficacy across multiple healthcare systems.
Languageen
PublisherElsevier
SubjectCardiac rehabilitation
Cardiovascular diseases
Cost
Developing countries
Developed countries
Economics
TitleCardiac rehabilitation costs
TypeArticle
dc.accessType Full Text


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record